Aina Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aina Zhou has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bo Shi
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China
28 shared publications - Danyang Shen
The First Affiliated Hospital of Soochow University 6 Department of General Surgery Suzhou, China
28 shared publications - Diyuan Zhou
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China
28 shared publications - Guoliang Chen
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China
28 shared publications - Huihui Yao
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China
28 shared publications - Jiancheng Xu
Cancer Institute, Suzhou Medical College, Soochow University, Suzhou, China
28 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S3. Information of antibodies.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S3. Information of antibodies.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S4. RNAi targets sequences.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S4. RNAi targets sequences.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S2. Primers used in RT-qPCR and vitro transcription.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S2. Primers used in RT-qPCR and vitro transcription.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S3. In AOM/DSS model mice, antibiotic treatment significantly attenuated the colon tumorigenesis.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S3. In AOM/DSS model mice, antibiotic treatment significantly attenuated the colon tumorigenesis.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S5. In vitro, circ_38945 promotes proliferation and migration.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S5. In vitro, circ_38945 promotes proliferation and migration.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S2. IF of the tight junction proteins ZO-1 and Occludin in AOM/DSS model mice subjected to three different treatment methods and IHC staining of the Ki-67 in the colon of mice subjected to two different treatment methods.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S2. IF of the tight junction proteins ZO-1 and Occludin in AOM/DSS model mice subjected to three different treatment methods and IHC staining of the Ki-67 in the colon of mice subjected to two different treatment methods.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S6. Stable cells with circ_0126925 knockdown or overexpression.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
S6. Stable cells with circ_0126925 knockdown or overexpression.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S1. Clinical information of 96 patients
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S1. Clinical information of 96 patients
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S5. Digoxin labeled probes, Cy3 labeled probes, Desthio Biotin-TEG labeled probes
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Table S5. Digoxin labeled probes, Cy3 labeled probes, Desthio Biotin-TEG labeled probes
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Figure S7. Mass spectrometry analysis of the BCAT2, keratin 19 and ACOT7 peptides pulled down by antisense circ_0126925 probes.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Gut Microbiota–Mediated hsa_circ_0126925 Targets BCAA Metabolic Enzyme BCAT2 to Exacerbate Colorectal Cancer Progression
Figure S7. Mass spectrometry analysis of the BCAT2, keratin 19 and ACOT7 peptides pulled down by antisense circ_0126925 probes.